首页>The Journal of Nuclear Medicine>Improved Estrogen Receptor Assessment by PET Using the Novel Radiotracer F-18-4FMFES in Estrogen Receptor-Positive Breast Cancer Patients: An Ongoing Phase II Clinical Trial
Improved Estrogen Receptor Assessment by PET Using the Novel Radiotracer F-18-4FMFES in Estrogen Receptor-Positive Breast Cancer Patients: An Ongoing Phase II Clinical Trial